Description

Global Market Watch:
The global PCR market is projected to reach around US$27.4 billion by 2015, with a Compounded Annual Growth Rate (CAGR) of 13.9% for the analysis period, 2009-2015. North America is estimated as the largest market with a market share of 40% of global market and projects US$10.7 billion by end-2010. Europe and Asia-Pacific together account for more than 50% of the global market share. Interestingly, Latin America is seen as the fastest growing market with a CAGR of 14.8%, to worth around US$1.3 billion in 2015.

Based on the classification by products/tools, PCR Reagents are expected to be fastest growing market with a CAGR of 14.6%. PCR Consumables and PCR Machines are expected grow with a CAGR of 14.2% and 13.1% respectively.

Report Focus:
The report “Polymerase Chain Reaction (PCR): Products/Tools – A Global Market Watch, 2009-2015” reviews the latest PCR market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:

· Emerging market trends

· Advancements in the technological space

· Market demand of the segments (by-region)

· Key growth areas and market size

· Key competitor’s Edge

The analysis primarily deals with major PCR product/tools market. Further, the subdivided categories include:

PCR Product/Tools

· PCR Machines

· PCR Reagents

· PCR Consumables

· Other (Software, Pipetting Robot & etc.,)

The period considered for the PCR market analysis is 2009-2015.  The region wise distribution of the market consists of North America (USA and Canada), Europe (France, Germany, United Kingdom, Italy, Spain and Rest of Europe), Asia- Pacific (Japan, China, India, Korea and Rest of Asia-Pacific), Latin America (Brazil, Columbia, Argentina and Rest of Latin America) and Rest of the World. Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.

More than 810 leading market players are identified and 53 key companies that project improved market activities in the near future are profiled. The report consists of 117data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

The broad ‘life science’ division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. Accelerating growth rate exhibited by the PCR industry, even during the recession years, confirms the positive growth prospects going ahead. Among the major developments in the recent years, gene amplification technology indicates the highest potential growth. Molecular diagnostics and the Human Genome Project (HGP) are two of the main drivers that contribute to the growth of gene amplification technology. It covers all segments such as drug discovery, DNA amplification, forensic identification, gene therapy and diagnosis. Freshly developed PCR Instruments for detecting most of the life threatening diseases also signal positive demand growth. Among the PCR types, q-PCR is expected witness the largest CAGR during 2009-2015.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the PCR industry. Anticipated of protracted economic recovery towards to 2011, we have used CAGR to forecasts to 2011 till 2015.

Table of Contents

I. REPORT FOCUS

PRODUCT/TOOLS IN PCR

A. INTRODUCTION

DEFINING POLYMERASE CHAIN REACTION

SCOPE OF POLYMERASE CHAIN REACTION

HISTORY OF POLYMERASE CHAIN REACTION

VARIATIONS OF POLYMERASE CHAIN REACTION

ALLELE-PRECISE PCR

PCA (POLYMERASE CYCLING ASSEMBLY) OR ASSEMBLY PCR

ASYMMETRIC PCR

HELICASE-RELIANT AMPLIFICATION

HOT–START PCR

INTERSEQUENCE-SPECIFIC PCR

REVERSE PCR

LIGATION MEDIATED PCR

METHYLATION SPECIFIC PCR

MINIPRIMER PCR

MULTIPLEX LIGATION-RELIANT PROBE AMPLIFICATION

MULTIPLEX PCR

NESTED PCR

OVERLAP-EXTENSION PCR

QUANTITATIVE PCR

RT-PCR

SOLID-PHASE PCR

TAIL-PCR

TOUCHDOWN PCR

PAN-AC

UNIVERSAL FAST WALKING

MERITS & DEMERITS OF POLYMERASE CHAIN REACTION

OPTIMIZING POLYMERASE CHAIN REACTION

THERMAL CYCLERS (POLYMERASE CHAIN REACTION)

PHASES OF POLYMERASE CHAIN REACTION

PARAMETERS FOR SUCCESSFUL PCR

I) METAL ION COFACTORS AND PCR

II) SUBSTRATES AND SUBSTRATE ANALOGS FOR PCR

III) BUFFERS AND SALTS FOR PCR

IV) COSOLVENTS

THERMAL CYCLING CONSIDERATIONS

I) PCR VESSELS

II) TEMPERATURE AND CYCLE TIME OPTIMIZATION

III) PCR AMPLIFICATION CYCLE NUMBER

IV)  ENZYME / TARGET

V) HOT START CONDITIONS

THEORY AND METHODOLOGY OF POLYMERASE CHAIN REACTION

METHODOLOGY OF USE

PCR – IMPROVISED TECHNIQUE FOR TESTING NUCLEIC ACIDS

FINAL ELONGATION

POLYMERASE CHAIN REACTION IN CLINICAL DETECTIONS

B. PRODUCT/TOOLS IN POLYMERASE CHAIN REACTION (PCR)

PCR MACHINES

REAL-TIME PCR MACHINES

REAL-TIME PCR INSTRUMENTATION

PCR REAGENTS

ROLE OF PCR REAGENTS

GOTAQ® PCR MIX

PRIMERS

NEXT GENERATION PCR REAGENTS FOR CLINICAL DIAGNOSTICS

PCR REAGENT MARKET TRENDS

DNA TEMPLATE

PCR CONSUMABLES

OTHER

PCR SOFTWARE

PCR ROBOTICS

THE AUTOMATION AND USAGE OF ROBOTICS IN AMPLIFICATION ASSAYS

PRE-PCR ROBOTIC SYSTEM

THE POST-PCR ROBOTIC SYSTEM

INTEGRATED ROBOTIC SYSTEM FOR HIGH SAMPLE THROUGHPUT WITHIN A DNA DATABASING UNIT

PCR ARRAYS

NEED OF PCR ARRAYS

DOCTRINE OF ASSAY CORROBORATION FOR NUCLEIC ACID DIAGNOSTIC TESTS

ASSAY CORROBORATION – AN INTRODUCTION

SELECTING AN ASSAY FITTING ITS INTENDED PURPOSE

CONSIDERATIONS TOWARDS PRIMITIVE ASSAY DEVELOPMENTS

A) CARE AND RESTRAINTS

B) PROTECTIONS FOR AVOIDING FALSE-POSITIVE RESULTS

C) SAFEGUARDS FOR AVOIDING NEGATIVE OUTCOMES

D) STANDARDS’ PREPARATION

ASSAY CORROBORATION - PART I

1. REAGENTS’ OPTIMIZATION BESIDES STANDARDIZATION AND ASCERTAINING
CRUCIAL CHECKING PARAMETERS

2. REPRODUCIBILITY

3. DIAGNOSTIC PARTICULARITY AND SENSITIVITY DETERMINATION

ASSAY CORROBORATION - PART 2

1. ASSAY CONDUCT’S PERFORMANCE DETERMINATION

A) ANIMAL POPULATION’S REFERENCE

I) REFERENCE ANIMALS’ NEGATIVITY

II) REFERENCE ANIMALS’ POSITIVITY

III) OTHER ASSAYS’ DETERMINATION OF STATUS OF REFERENCE ANIMALS

2. ENTRY-LEVEL DETERMINATION

ASSAY CORROBORATION - PART 3

1. STARTING ASSAY REPRODUCIBILITY

ASSAY CORROBORATION - PART 4

1. CURRICULUM ACCOMPLISHMENT

2. OBSERVING ASSAY FUNCTIONING’S VALIDITY

A) EXPLANATION OF ANALYSES’ RESULTS – ISSUES UPSETTING ASSAY VALIDITY

B) MAINTAINING CORROBORATION CRITERIA

POLYMERASE CHAIN REACTION (PCR) - PRODUCT/TOOLS - GEOGRAPHY MARKET BRIEFING

NORTH AMERICA

EUROPE

ASIA-PACIFIC

LATIN AMERICA

REST OF WORLD

II. MARKET ANALYSIS

POLYMERASE CHAIN REACTION (PCR): PRODUCT/TOOLS – INDUSTRY SNAPSHOT

A. POLYMERASE CHAIN REACTION (PCR): PRODUCT/TOOLS - SEGMENTATION

POLYMERASE CHAIN REACTION (PCR) - GLOBAL

POLYMERASE CHAIN REACTION (PCR) - GEOGRAPHIC REGION

POLYMERASE CHAIN REACTION (PCR) - BY COUNTRY ANALYSIS

NORTH AMERICA

EUROPE

ASIA-PACIFIC

LATIN AMERICA

POLYMERASE CHAIN REACTION (PCR) – BY PRODUCT/TOOLS

POLYMERASECHAINREACTION (PCR) - PRODUCT/TOOLS - GEOGRAPHICREGION

PCR MACHINES

NORTH AMERICA

EUROPE

ASIA-PACIFIC

LATIN AMERICA

REST OF WORLD

PCR REAGENTS

NORTH AMERICA

EUROPE

ASIA-PACIFIC

LATIN AMERICA

REST OF WORLD

PCR CONSUMABLES

NORTH AMERICA

EUROPE

ASIA-PACIFIC

LATIN AMERICA

REST OF WORLD

OTHER PCR PRODUCT/TOOLS

NORTH AMERICA

EUROPE

ASIA-PACIFIC

LATIN AMERICA

REST OF WORLD

B. GROWTH RATE ANALYSIS

GLOBAL POLYMERASE CHAIN REACTION (PCR) - MARKET GROWTH RATES

POLYMERASE CHAIN REACTION (PCR) MARKET - PRODUCT/TOOLS

GLOBAL PCR PRODUCT/TOOLS - GROWTH RATES

PCR MACHINES

MARKET GROWTH RATES FOR PCR PRODUCT/TOOLS – PCR MACHINES

PCR REAGENTS

MARKET GROWTH RATES FOR PCR PRODUCT/TOOLS – PCR REAGENTS

PCR CONSUMABLES

MARKET GROWTH RATES FOR PCR PRODUCT/TOOLS – PCR CONSUMABLES

C. INVESTMENT FOCUS

III. INDUSTRY OVERVIEW

A. INDUSTRY ACTIVITIES

MERGERS/ACQUISITIONS/AGREEMENTS/PATENTS GRANTS/JOINT VENTURES/INNOVATIONS/PRODUCT LAUNCHES/ETC……

GENEWORKS CHAINS THE HUMAN MITOCHONDRIAL TRANSCRIPTOME

EPPENDORF GETS LICENSES TECHNOLOGY FOR THERMAL CYCLERS TO BULLDOG BIO

CALIPER LAUNCHES ZEPHYR NGS POST-PCR WORKSTATION

HKSH SELECTS GE HEALTHCARE’S PET/CT+MR FOR MANAGEMENT OF DISEASES

ABBOTT INTRODUCES ALK GENETIC TEST FOR NSCLC

QIAGEN ACQUIRES CELLESTIS

ABBOTT OBTAINS FDA APPROVAL FOR ALK GENE TEST

BIONEER RELEASES H1N1 VIRUS DIAGNOSTIC KIT 

COMPLETE GENOMICS TO SEQUENCE DNA FOR NCI’S PEDIATRIC CANCER STUDY

ABBOTT GETS FDA CLEARANCE FOR VYSIS CLL FISH PROBE KIT 

ABBOTT ANNOUNCES SUCCESSFUL TREATMENT OF THE FIRST PATIENT IN JAPAN WITH ABSORB™ BIORESORBABLE VASCULAR SCAFFOLD

QIAGEN AND PFIZER ANNOUNCE PARTNERSHIP

ABBOTT GETS FDA APPROVAL FOR RX HERCULINK ELITE® RENAL STENT SYSTEM

ABBOTT INTRODUCES PLEX-ID™ VECTOR-BORNE TEST

BIOGEN IDEC AND ABBOTT ANNOUNCE SUCCESS OF SELECT TRIAL FOR RRMS

QIAGEN INAUGURATES TAIWAN SUBSIDIARY IN TAIPEI

QIAGEN COMPLETES SECOND U.S. SUBMISSION FOR THERASCREEN® KRAS RGQ PCR KIT

ILLUMINA AND THE UNIVERSITY OF OXFORD COLLABORATE FOR PERSONALIZED MEDICINE

BD SIGNS AGREEMENT TO ACQUIRE CARMEL PHARMA

STARTING UP THE GENE THERAPY PROJECT IN CHINA

PROMEGAPOWERPLEX® 18D SYSTEM OBTAINS NDIS APPROVAL FOR OFFENDER DNA PROFILING

AFFYMETRIX STARTS SHIPMENT OF GENE PROFILING REAGENTS

LIFE TECHNOLOGIES INTRODUCES APPLIED BIOSYSTEMSVETMAXTM-GOLD SIV DETECTION KIT

BIOTAGE INTRODUCES MICROWAVE PEPTIDE SYNTHESIZER

RAISING THE BAR IN MICROWAVE SYNTHESIS BY BIOTAGE

COMPLETE GENOMICS INTRODUCES CANCER GRANT PROGRAM 

PROMEGA INTRODUCES BIOLUMINESCENT HDAC ASSAYS

QIAGEN PREPARES PROPOSAL TO FULLY ACQUIRE IPSOGEN

ENZOBIOCHEM SIGNS AGREEMENT WITH INCELLDX AGREE TO MARKET HPV ONCOTECT™ TEST

EUROFINSMEDIGENOMIX’S NEW SERVICE FOR TESTING OF DNA CONTAMINATION

NEW SOFTWARE SPEEDS VALIDATION OF AUTOMATED LIQUID HANDLING PROCESSES

ABBOTT OBTAINS CE MARK FOR ITS REAL TIME PCR TEST FOR CMV

BD DIAGNOSTICS LAUNCHES BD MAX™ IN THE U.S.

LABSCO SET TO DISTRIBUTE CEPHEID’S GENEXPERT SYSTEMS

ABBOTT GETS FDA APPROVAL FOR MOLECULAR TEST FOR HEPATITIS C

AGILENT ANNOUNCES 2011 MANFRED DONIKE AWARD FOR EXCELLENCE IN SPORTS-DOPING DETECTION

ROCHE DIAGNOSTICS LAUNCHES ITS NEW BLOOD GAS ANALYZER

ROCHE DIAGNOSTICS LAUNCHES THE COBAS® 8000 MODULAR ANALYZER

LIFE TECHNOLOGIES INTRODUCES 7500 FAST DX REAL-TIME PCR INSTRUMENT AND 3500 DX SERIES GENETIC ANALYZER IN JAPAN

AFFYMETRIX, FIRST IN THE INDUSTRY TO ACHIEVE FDA CLEARANCE FOR MICROARRAY-BASED GENE EXPRESSION REAGENTS

CALIPER ANNOUNCES RESEARCH COLLABORATION WITH CHI

AFFYMETRIX LAUNCHES SECOND GENERATION ONCOSCAN™ FFPE EXPRESS 2.0

AGILENT TECHNOLOGIES LAUNCHES AGILENT SURECYCLER 8800

LIFE TECHNOLOGIES FORTIFIES ITS DNA SEQUENCING PLATFORM

GENSCRIPT LAUNCHES GANP® TECH SERVICES GLOBALLY EXCLUDING JAPAN

ABBOTT RECEIVES CE MARK FOR NEW PCR-BASED HIV-1 TEST

QIAGEN RECEIVES SFDA APPROVAL FOR CAREHCV RT-PCR KIT V2

BD ACQUIRES ACCURI CYTOMETERS

AFFYMETRIX INTRODUCES SNP CORE REAGENT KIT FOR SNP ARRAY 6.0 CUSTOMERS

CALIPERS AND HISTORX JOINT VENTURE FOR TISSUE-BASED INTEGRATED SOLUTIONS FOR PROTEIN QUANTIFICATION OF BIOMARKERS

CYTOCELL DEVELOPS NEW FGFR1 FISH PROBE

AFFYMETRIX UNVEILS NEXT-GENERATION MICRORNA SOLUTION

INTEGENX AND CALIPER SIGN LICENSE AGREEMENT

CYTOCELL STARTS DISTRIBUTION IN BULGARIA

TAKARA BIO ESTABLISHES A SUBSIDIARY …

GENE LOGIC INTRODUCES ASCENTA 4.0 WITH SUPERIOR FUNCTIONALITY

PROMEGA AND FUGENT LLC SIGN AGREEMENT FOR SUPPLY OF FUGENE® 6

ABBOTT’S IBIS TECHNOLOGY TO IDENTIFY ORGANISM CAUSING PLAGUE IN AFGHANISTAN

ABBOTT PRESENTS THE PLEX-ID™ BIOTHREAT ASSAY

CYTOCELL LAUNCHES FIVE NEW T-CELL ALL FISH PROBES

PROMEGA LAUNCHES RELIAPREP™ BLOOD AND TISSUE GDNAMINIPREP SYSTEMS

LIFE TECHNOLOGIES LAUNCHES PCR DETECTION KIT FOR SALMONELLA ENTERITIDIS IN POULTRY EGGS

AFFYMETRIX LAUNCHES THE AXIOM(TM) GENOME-WIDE BOS 1 ARRAY FOR BOVINE GENOTYPING

ILLUMINA ACQUIRES EPICENTRE BIOTECHNOLOGIES

ILLUMINA AFFIRMS MISEQ(TM) PERSONAL SEQUENCING SYSTEM’S ADVANTAGES

ILLUMINA INTRODUCES NEXT GENERATION OF ISELECT(R) CUSTOM GENOTYPING PRODUCTS

BIOSPECTRUM HONORS OCIMUM BIOSOLUTIONS AS THE BEST BIOINFORMATICS COMPANY

CALIPER ACQUIRES CRI

CMB AND BIO RAD PARTNER TO DEVELOP DNA BARCODING INSTRUCTIONAL ACTIVITIES 

SPARTAN RX CYP2C19 RECEIVES CE MARKING

OCIMUM CLOSES $8 MILLION TO FUEL FUTURE GROWTH

CALIPER SIGNS AGREEMENT TO ACQUIRE CRI

AGILENT AND UC DAVIS COLLABORATE FOR FOOD SAFETY RESEARCH

LIFE TECHNOLOGIES LAUNCHES APPLIED BIOSYSTEMSVETMAX-GOLD BVDV DETECTION KIT

ONLINE QUOTATION SYSTEM FOR POLYCLONAL ANTIBODY SERVICE BY GENSCRIPT

IMMUNOLOGIX TEAMS WITH GENSCRIPT

ILLUMINA INTRODUCES TRUSEQ(TM) SAMPLE PREP AND EXOME ENRICHMENT KITS

ADDITION OF GENE EDITING TECHNOLOGY

AXIOM ANALYTICAL’S ACCURATE TEMPERATURE CONTROL WITH FIBER-OPTIC

QIAGEN LAUNCHED STANDARDIZED SOLUTIONS FOR MOLECULAR ANALYSIS OF FFPE SAMPLES

TAKARA BIO GETS ANTI-CANCER DRUG

FDA CONSENTS ROCHE'S REAL-TIME PCR COBAS TAQMAN HCV TEST, V2.0

SPRYCEL OBTAINS CHMP POSITIVE OPINION FOR NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME POSITIVE CML IN CHRONIC PHASE

NEW ENGLAND BIOLABS, INC. LAUNCHES PCR-BASED ASSAY TO IDENTIFY AND QUANTITATE 5-HMC IN EPIGENOME.

LEADING UK HOSPITAL DEMONSTRATES DETECT-READY™ MRSA OF MOLECULAR DETECTION INC.

EXIQON CUSTOM DESIGNS IN SITU HYBRIDIZATION

CHINA MEDICAL TECHNOLOGIES, INC.- A PIONEER RECEIVED APPROVAL FOR FIRST EVER SELF-DEVELOPED EGFR PCR ASSAY FOR LUNG CANCER TARGETED DRUGS

CORNING COMPLETES ACQUISITION OF PLASLAB S.A.S.

BOEHRINGERINGELHEIM AND EUROFINSMEDIGENOMIX GMBH SIGN SERVICE AGREEMENT FOR DNA BANKING AND PHARMACOGENETICS / PHARMACOGENOMICS

BIOFORTUNA LTD. RELEASES WORLD'S FIRST FREEZE-DRIED SOLUTION

ANASPEC, INC. LAUNCHES MESA BLUE QPCR MIXES FOR SYBR(R) ASSAY

OMEROS CORPORATION - SPOTTED CHEMOTHERAPEUTIC BUSTLE

VIRACOR-IBT LABORATORIES INTRODUCES ASPERGILLUS PCR PANEL AND ADVANCES FUNGAL TESTING SERVICES

SEEGENE, INC. READ PCR HAS INVENTED THE TESTS FOR BOTH TB AND SEXUALLY TRANSMITTED DISEASE

QIAGEN’S NEW AUTOMATED MODULAR TESTING PLATFORM FOR MOLECULAR DIAGNOSTICS

AGILENT AUTOMATION SOLUTIONS REVELS THE WAYS TO LEAD SUCCESSFUL QPCR AUTOMATION

EPPENDROF’S DIVISIBLE PCR PLATES

QUANTALIFE TRIUMPHS WITH $820K FROM NIH TO DEVELOP MRSA TEST FOR DIGITAL PCR PLATFORM

FOURTH ANNUAL QPCR SYMPOSIUM IN USA TO BE HOSTED BY INTELLIGENT ENTERPRISE SOLUTIONS, INC.

TRANSGENOMIC, INC. (TBIO) DEVELOPS NEW ASSAYS TO DETECT EGFR MUTATIONS

PROMEGA ADVANCES THROUGH NEW GOTAQ® 2-STEP RT-QPCR SYSTEM

WAFERGEN BIOSYSTEMS ENTERS INTO A DISTRIBUTION AGREEMENT OF SMARTCHIP REAL-TIME PCR

ASURAGEN REVELS THE USES OF PCR-ONLY TECHNOLOGIES WITH ITS COLLABORATORS

BIOSERVE’S COST EFFECTIVE PCR-BASED GMO SCREENING TESTS

ROCHE AND EXIQON – JOINT VENTURE FOR THEIR RT PCR ASSAY SYSTEMS

EMIR DUZIC TO LEAD GPCR ASSAY SERVICES FOR CHANTEST CORPORATION

TREVENA, INC. SAFE AND SOUND COMPLETE PHASE 2 STUDY OF TRV120027 FOR ACUTE HEART FAILURE

ROCHE OBTAINS CO-EXCLUSIVE LICENSE FROM QIAGEN INC.

MILLIPORE CORPORATION ENABLE NEW INSIGHTS INTO GPCR ACTIVITY

ABBOTT RECEIVES FDA APPROVAL FOR MOLECULAR DIAGNOSTIC TEST FOR GONORRHEA AND CHLAMYDIA DETECTION

OMEROS UNLOCKS ORPHAN GPCRS

KYOTO UNIVERSITY TO USE SMARTCHIP REAL-TIME PCR BY WAFERGEN BIOSYSTEMS TO DIFFERENTIATE BIOMARKERS

ENDOGENOUS GPCRS USING THE XCELLIGENCE SYSTEM FOR FUNCTIONAL CELL PROFILING

EXIQON AND MULTID ENTERS INTO AN AGREEMENT TO TAILOR MICRORNA QPCR ANALYSIS SOLUTION

ERAGEN BIOSCIENCES INC. CLEARS FDA FOR ITS FIRST HERPES SIMPLEX VIRUS PCR TEST

WAFERGEN BIOSYSTEMS LAUNCHES BREAKTHROUGH SMARTCHIP REAL-TIME PCR SYSTEM

AFFYMETRIX LAUNCHES AFFYMETRIX(R) MIP COPY NUMBER SERVICE FOR CHALLENGING FFPE SAMPLES

ROCHE´S LIGHTCYCLER® 1536 INSTRUMENT WILL BE USED BY GHENT UNIVERSITY IN THE FIELD OF HT PCR FOR CANCER RESEARCH

THERMO FISHER SCIENTIFIC INC., HELPS RESEARCHERS FOR PCR PLASTICS

FDA GIVES APPROVAL TO NEW ROCHE DUAL-PCR TARGET HIV-1 TEST

THE U.S. PATENT AND TRADEMARK OFFICE ISSUES EXCLUSIVE PATENT TO IDAHO TECHNOLOGY

ABBOTT AND GSK COLLABORATE FOR MOLECULAR DIAGNOSTIC TEST FOR MAGE-A3 ASCI ELIGIBILITY

AFFYMETRIX RELEASES GENEATLAS™ PERSONAL MICROARRAY SYSTEM FOR WHOLE-GENOME ANALYSIS 

LIFE TECHNOLOGIES ADDS IVD MARK FOR REAL-TIME PCR INSTRUMENT

CONVENTIONAL PCR AND REAL-TIME PCR TECHNIQUES BY SEEGENE, INC. WITH NEW POTENTIAL PLATFORM FOR NEW MOLECULAR DIAGNOSTIC TESTS

QUANTALIFE LAUNCHED DROPLET DIGITAL(TM) PCR SYSTEM

ABBOTT RECEIVES CE MARK FOR NEW GENE-BASED TEST FOR COLORECTAL CANCER

THE SCIENTIST’ NAMES ABBOTT’S IBIS TECHNOLOGY ONE OF THE TOP INNOVATIONS FOR 2009

A SMARTCHIP™ REAL-TIME PCR SYSTEM LAUNCHED BY WAFERGEN BIOSYSTEMS AS A HUMAN MICRORNA PANEL FOR GENE-EXPRESSION PROFILING OF 885 MICRORNA.

DXNA'S GENESTAT™ - DETECTION OF INFLUENZA H1N1 VIRUS GETS AUTHORIZED BY FDA.

THE INVENTION OF MORE ACCURATE PCR PRODUCTS BY THERMO FISHER SCIENTIFIC INC.

WAFERGEN BIOSYSTEMS INTRODUCES A NEW GENE-EXPRESSION PROFILING SERVICE USING THE SMARTCHIP™ REAL-TIME PCR SYSTEM.

INNOVATION OF AUTOMATED PCR DX FOR HLA AND COELIAC DISEASE.

CELLAURA TECHNOLOGIES LTD TIES UP WITH CISBIO BIOASSAYS TO DEVELOP REAGENTS FOR TAG-LITE™ GPCR TECHNOLOGY.

EXIQON A/S LAUNCHES A NEW MICRORNA QPCR EXPRESSION PLATFORM.

TRANSGENOMIC, INC. SIGNS AN AGREEMENT WITH DANA-FARBER CANCER INSTITUTE FOR COLD-PCR TECHNOLOGY.

A BRAND-NEW WORKSTATION FOR PCR BY HOEFER, INC.

A NEW GENOMIC ANALYSIS TOOLS LAUNCHED

QIAGEN ADOPTS HRM TECHNOLOGY IN GENOTYPING

DXS LTD MERGES WITH QIAGEN

ROCHE AND IDAHO TECHNOLOGY OFFERS PCR LICENSE TO QIAGEN

ABBOTT AND PFIZER PARTNER FOR COMPANION DIAGNOSTIC TEST TO SCREEN NSCLC

CELEBRATIONS AT THERMO FISHER SCIENTIFIC (TMO)

BIOSTATUS LTD.'S DRAQ5 – A BEQUEST TO GENETIC STUDY

ABBOTT COLLABORATES WITH GSK FOR MOLECULAR DIAGNOSTIC TEST FOR MAGE-A3 ANTIGEN

NEW PCR ASSAYS TO QUANTIFY PROTEIN IN HUMAN CELLS

RT-PCR TECHNOLOGY TO PROVIDE DIAGNOSTIC TESTS FOR SWINE H1N1 INFLUENZA

LAB901’S NEW PRODUCT

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES OFFERS GRANT TO CEPHEID

ELITECH MERGES WITHNANOGEN

ABBOTT REALTIME VIRAL LOAD TEST RECOMMENDED FOR NIH-SPONSORED CLINICAL TRIALS

ROCHE DIAGNOSTICS CORPORATION MAKES TUBERCULOSIS TESTING EASIER

NEW REAL-TIME PCR SOLUTION LAUNCHED BY APPLIED BIOSYSTEMS

LUCRATIVE FAST PCR TEST-KITS FOR HIV/AIDS TESTING EMERGE WITH A COLLABORATION OF SPARTAN BIOSCIENCE AND COOPERATIVE DIAGNOSTICS.

BIOXPR SA ANNOUNCES NEW PROPOSALS AND SERVICES IN GENETIC ANALYSIS

SPARTAN BIOSCIENCE SPREADS ITS ROOTS IN DNA MARKET

ENZO BIOCHEM TAKES OVER ASSAY DESIGNS INC.

HIGH RANGE THROUGHPUT FOR DIGITAL PCR BY FLUIDIGM CORPORATION'S NOVEL DIGITAL ARRAY

NANOGEN EXPANDS ITS PARTNERSHIP

NOVEL GPCR ASSAY STRATEGY GRANTED PATENT

OPENARRAY® DLP REAL-TIME QPCR PLATFORM- A NEW INTRODUCTION BY BIOTROVE

NEW LAUNCHES OF BIOTROVE, INC.

ABBOTT INTRODUCES REALTIME HIGH RISK HPV ASSAY IN EUROPE

FLUIDIGM IN EARLY DETECTION OF LEUKEMIA

QIAGEN AND APPLIED BIOSYSTEMS SETTLES A SINGLE PATENT FOR REAL-TIME THERMAL CYCLER

GLOBAL LICENSE AGREEMENT BETWEEN EVOGEN AND LGC ON NOVEL HYBEACONS(R)

ROLE OF PCR AND FCR IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA

FINDINGS OF US ONCOLOGY, INC. (USON) IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA

EPPENDORF TO CHECK EVAPORATION IN PCR TESTING.

ASURAGEN, INC. INSTIGATES A MULTIPLEX QRT-PCR ASSAY.

PANOMICS TAKE OVER BY AFFYMETRIX

SUNSHINE BIO INVESTMENTS WORLD FUNDS MULTI-BILLION DOLLAR NORTH AMERICAN MARKETS

LICENSING AGREEMENT BETWEEN MP BIOMEDICALS, INC. AND A*STAR

UPGRADED VERSION OF ENIGMA FIELD LABORATORY (FL) INVENTED BY ENIGMA DIAGNOSTICS.

INTEGRATED DNA TECHNOLOGIES’ FIRST ASSAY PRODUCT.

A NEW APPROACH TO REAL-TIME PCR ANALYSIS

TAQMAN® SAMPLE-TO-SNP™ KIT-A GIFT TO LIFE SCIENCES INDUSTRY.

COMPLETE GENOMICS DECLARED AS WORLD’S FIRST LARGE-SCALE HUMAN GENOME SEQUENCING COMPANY

INTEGRATED DNA TECHNOLOGIES ACQUIRES LICENSE FOR REAL-TIME PCR PROBE LICENSING PROGRAM

SEQUENOM INC. AND GENOMIC NANOSYSTEMS HAS A LICENSE AGREEMENT.

A SERVICE PROVIDER PROGRAM LAUNCHED BY APPLIED BIOSYSTEMS, INC.

FORENSIC DNA ANALYSIS - EPSYSTEM GUIDE NO.12.

METAHELIX LIFE SCIENCES TO TEAM UP WITH SIGMA-ALDRICH

QIAGEN TAKES OVER CORBETT LIFE SCIENCE

PALM-SIZE PORTABLE PCR DEVICE BY AHRAM BIOSYSTEMS.

REAL-TIME PCR TECHNOLOGY FOR FORENSICS DNA ANALYSIS

REAL-TIME PCR AN ADDITION TO BIO-RAD’S COLLECTION.

NEW SOLUTIONS FOR LEAD OPTIMIZATION AND CELL-BASED GPCR PROFILING.

BIOTECON DIAGNOSTICS ENTERS INTO AGREEMENT WITH APPLERA CORPORATION

TRIMGEN CORPORATION AND SPARTAN BIOSCIENCE OFFERS REAL-TIME PCR SOLUTIONS

INVITROGEN AND GENISPHERE COME TOGETHER FOR ADVANCE EPIGENETIC RESEARCH 

AFFYMETRIX ACQUIRES USB CORPORATION

WAFERGEN LAUNCHES SUBSIDIARY AT KEDAH, MALAYSIA

ROSETTA GENOMICS LICENSED USER OF PCR TECHNOLOGY

B. MARKET TRENDS

SPARTAN BIOSCIENCE DX-12 ™ DNA ANALYZER – A BOON TO BIOTECHNOLOGY

REDDYMIX - A BUFFER FOR PCR REAGENTS

NEXT GENERATION PCR APPROVES EVOLUTION POLYMERASES

QUICKPROBE(TM) QPCR- A BONUS TO LIFE SCIENCES COMPANIES

MASTER CLEAR CAP STRIPS® - AN ADDITION TO PCR CONSUMABLES

DIGITAL PCR TECHNOLOGY BY FLUIDIGM

GREENECHIP TECHNOLOGY- UNPREJUDICED PATHOGEN DISCOVERY

INCREASING DEMAND FOR QRT-PCR PRODUCTS

QIAGEN’S NEW SOLUTION TO ACCELERATE PCR

OPTO TECHNOLOGY’S NEW INVENTION - OTHP-0050

TIE UP BETWEEN FISHER BIOSCIENCES AND APPLIED BIOSYSTEMS

FISHER BIOSCIENCES AND DYOMICS MERGE FOR BETTERMENT

PCR MACHINES - IMPACT ON LIFE SCIENCES EQUIPMENT.

C. INDUSTRY LEADERS

ABBOTT LABORATORIES (USA)

AGILENT TECHNOLOGIES INC (USA)

APPLIED BIOSYSTEMS INC (USA)

BIONEER INC (USA)

COMPLETE GENOMICS, INC. (USA)

EPICENTRE® BIOTECHNOLOGIES (USA)

GENISPHERE INC. (USA)

MAXIM BIOTECH, INC (USA)

OCIMUM BIOSOLUTIONS LTD.

QIAGEN INC (USA)

SACACE BIOTECHNOLOGIES S.R.L. (ITALY)

TAKARA BIO, INC.

THERMO FISHER SCIENTIFIC, INC.

LIGHTUP TECHNOLOGIES AB (SWEDEN)

HY LABORATORIES LTD. (ISRAEL)

D. POLYMERASE CHAIN REACTION (PCR) – A LOOK A HEAD..!!

E. KEY COMPANY PROFILES

NORTH AMERICA

EUROPE

ASIA-PACIFIC

REST OF WORLD

IV. INDUSTRY COMPANY DATABASE

V. APPENDIX

A. RESEARCH FOCUS

B. ABOUT AXIS RESEARCH MIND

C. DISCLAIMER

D. FEEDBACK

List of Tables/Charts

I. REPORT FOCUS

1. PCR THERMOCYCLER BRANDS BY KEY PLAYERS

2. WORLDWIDE KEY PLAYERS MARKET SHARES OF Q-PCR REAGENTS - (2009-2010)

POLYMERASE CHAIN REACTION (PCR): PRODUCT/TOOLS - GEOGRAPHY MARKET BRIEFING

3. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER FOR NORTH AMERICA - (2009-2015, IN USD$ MILLION)

4. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER - % OF NORTH AMERICAN MARKET VALUE - (2010 - 2015)

5. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER FOR EUROPE - (2009-2015, IN USD$ MILLION)

6. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER - % OF EUROPEAN MARKET VALUE - (2010 - 2015)

7. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER FOR ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)

8. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER - % OF ASIA-PACIFIC MARKET VALUE - (2010 - 2015)

9. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER FOR LATIN AMERICA - (2009-2015, IN USD$ MILLION)

10. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER - % OF LATIN AMERICAN MARKET VALUE - (2010 - 2015)

11. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER FOR REST OF WORLD - (2009-2015, IN USD$ MILLION)

12. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER - % OF REST OF WORLD MARKET VALUE - (2010 - 2015)

II. MARKET ANALYSIS

A. POLYMERASE CHAIN REACTION (PCR): PRODUCT/TOOLS - SEGMENTATION

13. GLOBAL POLYMERASE CHAIN REACTION (PCR) – SEGMENTATION BY PRODUCT/TOOLS

B. POLYMERASE CHAIN REACTION (PCR) - GLOBAL

14. POLYMERASE CHAIN REACTION (PCR) MARKET - CURRENT TRENDS, ESTIMATES & FORECASTS- (2009-2015, IN USD$ MILLION)

15. PCR MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)

16. PCR MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2010 - 2015)

B1. POLYMERASE CHAIN REACTION (PCR) - BY COUNTRY ANALYSIS

17. PCR MARKET - USA AND CANADA - (2009-2015, IN USD$ MILLION)

18. PCR MARKET - % OF USA AND CANADA MARKET VALUE - (2010 - 2015)

19. PCR MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)

20. PCR MARKET - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN AND REST OF EUROPE MARKET VALUE - (2010 - 2015)

21. PCR MARKET - JAPAN, CHINA, INDIA, S&N KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)

22. PCR MARKET - % OF JAPAN, CHINA, INDIA, S&N KOREA AND REST OF ASIA-PACIFIC MARKET VALUE -
(2010 - 2015)

23. PCR MARKET - BRAZIL, COLUMBIA, ARGENTINA AND REST OF LATIN AMERICA - (2009-2015, IN USD$ MILLION)

24. PCR MARKET- % OF BRAZIL, COLUMBIA, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE -
(2010 - 2015)

I. POLYMERASE CHAIN REACTION (PCR) – BY PRODUCT/TOOLS

25. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER FOR GLOBAL CURRENT TRENDS, ESTIMATES &FORECASTS - (2009-2015, IN USD$ MILLION)

26. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER - % OF GLOBAL MARKET VALUE - (2010 - 2015)

POLYMERASE CHAIN REACTION (PCR) - PRODUCT/TOOLS - GEOGRAPHICREGION

I.A. PCR MACHINES

27. PCR MACHINES MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)

28. PCR MACHINES MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2010 - 2015)

29. PCR MACHINES MARKET - USA AND CANADA - (2009-2015, IN USD$ MILLION)

30. PCR MACHINES MARKET - % OF USA AND CANADA MARKET VALUE - (2010 - 2015)

31. PCR MACHINES MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)

32. PCR MACHINES MARKET - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN AND REST OF EUROPE MARKETVALUE - (2010 - 2015)

33. PCR MACHINES MARKET - JAPAN, CHINA, INDIA, S&N KOREA AND REST OF ASIA-PACIFIC - (2009-2015, INUSD$ MILLION)

34. PCR MACHINES MARKET - % OF JAPAN, CHINA, INDIA, S&N KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2010 - 2015)

35. PCR MACHINES MARKET - BRAZIL, COLUMBIA, ARGENTINA AND REST OF LATIN AMERICA - (2009-2015, INUSD$ MILLION)

36. PCR MACHINES MARKET - % OF BRAZIL, COLUMBIA, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2010 - 2015)

37. PCR MACHINES MARKET - REST OF WORLD - (2009-2015, INUSD$ MILLION)

I.B. PCR REAGENTS

38. PCR REAGENTS MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)

39. PCR REAGENTS MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2010 - 2015)

40. PCR REAGENTS MARKET - USA AND CANADA - (2009-2015, INUSD$ MILLION)

41. PCR REAGENTS MARKET - % OF USA AND CANADA MARKET VALUE - (2010 - 2015)

42. PCR REAGENTS MARKET- GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN AND REST OF EUROPE - (2009-2015, INUSD$ MILLION)

43. PCR REAGENTS MARKET - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN AND REST OF EUROPE MARKET VALUE - (2010 - 2015)

44. PCR REAGENTS MARKET - JAPAN, CHINA, INDIA, S&N KOREA AND REST OF ASIA-PACIFIC - (2009-2015, INUSD$ MILLION)

45. PCR REAGENTS MARKET - % OF JAPAN, CHINA, INDIA, S&N KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2010 - 2015)

46. PCR REAGENTS MARKET -BRAZIL, COLUMBIA, ARGENTINA AND REST OF LATIN AMERICA -(2009-2015, INUSD$ MILLION)

47. PCR REAGENTS MARKET - % OF BRAZIL, COLUMBIA, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2010 - 2015)

48. PCR REAGENTS MARKET - REST OF WORLD - (2009-2015, INUSD$ MILLION)

I.C. PCR CONSUMABLES

49. PCR CONSUMABLES MARKET -GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)

50. PCR CONSUMABLES MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2010 - 2015)

51. PCR CONSUMABLES MARKET - USA AND CANADA - (2009-2015, IN USD$ MILLION)

52. PCR CONSUMABLES MARKET - % OF USA AND CANADA MARKET VALUE - (2010 - 2015)

53. PCR CONSUMABLES MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)

54. PCR CONSUMABLES MARKET - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN AND REST OF EUROPE MARKET VALUE - (2010 - 2015)

55. PCR CONSUMABLES MARKET - JAPAN, CHINA, INDIA, S&N KOREA ANDREST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)

56. PCR CONSUMABLES MARKET - % OF JAPAN, CHINA, INDIA, S&N KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2010 - 2015)

57. PCR CONSUMABLES MARKET -BRAZIL, COLUMBIA, ARGENTINA AND REST OF LATIN AMERICA - (2009-2015, IN USD$ MILLION)

58. PCR CONSUMABLES MARKET - % OF BRAZIL, COLUMBIA, ARGENTINA AND REST OFLATIN AMERICA MARKET VALUE - (2010 - 2015)

59. PCR CONSUMABLES MARKET - REST OF WORLD - (2009-2015, IN USD$ MILLION)

I.D. OTHER PCR PRODUCT/TOOLS

60. OTHER PCR PRODUCT/TOOLS MARKET -GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)

61. OTHER PCR PRODUCT/TOOLS MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2010 - 2015)

62. OTHER PCR PRODUCT/TOOLS MARKET - USA AND CANADA - (2009-2015, IN USD$ MILLION)

63. OTHER PCR PRODUCT/TOOLS MARKET - % OF USA AND CANADA MARKET VALUE - (2010 - 2015)

64. OTHER PCR PRODUCT/TOOLS MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)

65. OTHER PCR PRODUCT/TOOLS MARKET - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN AND REST OF EUROPE MARKET VALUE - (2010 - 2015)

66. OTHER PCR PRODUCT/TOOLS MARKET - JAPAN, CHINA, INDIA, S&N KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)

67. OTHER PCR PRODUCT/TOOLS MARKET - % OF JAPAN, CHINA, INDIA, S&N KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2010 - 2015)

68. OTHER PCR PRODUCT/TOOLS MARKET -BRAZIL, COLUMBIA, ARGENTINA AND REST OF LATIN AMERICA - (2009-2015, IN USD$ MILLION)

69. OTHER PCR PRODUCT/TOOLS MARKET - % OF BRAZIL, COLUMBIA, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2010 - 2015)

70. OTHER PCR PRODUCT/TOOLS MARKET - REST OF WORLD - (2009-2015, IN USD$ MILLION)

C. GROWTH RATE ANALYSIS

GLOBAL POLYMERASE CHAIN REACTION (PCR) - MARKET GROWTH RATES

71.  PCR MARKET - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS - (2009-2015)

 

C.1. POLYMERASE CHAIN REACTION (PCR) MARKET - PRODUCT/TOOLS

GLOBAL PCR PRODUCT/TOOLS - GROWTH RATES

72. PCR PRODUCT/TOOLS - % GROWTH RATE FORECASTS FOR PCR MACHINES, PCR REAGENTS AND PCR CONSUMABLES - (2009-2015)

73. PCR MACHINES - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS - (2009-2015)

74. PCR REAGENTS - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS - (2009-2015)

75. PCR CONSUMABLES - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS - (2009-2015)

III. INDUSTRY OVERVIEW

76. LIST OF KEY PLAYERS WORLDWIDE FOR POLYMERASE CHAIN REACTION (PCR)

77. ABBOTT LABORATORIES: WORLDWIDE NET SALES AND R&D EXPENSES FOR THE YEARS - (2010-2009-2008 - USD BILLION)

78. ABBOTT LABORATORIES: WORLDWIDE BREAKDOWN OF NET SALES BY COUNTRY - (2010-2009-2008 - USD MILLION)

79. ABBOTT LABORATORIES: COMPONENTS OF SALES GROWTH BY REPORTABLE SEGMENT - (2010-2009-2008 - USD MILLION)

80. ABBOTT LABORATORIES: NET SALES WORLDWIDE AND NON-US - (2006-2010, IN USD MILLION)

81. AFFYMETRIX, INC.: NET SALES BY GEOGRAPHIC REGION - (2010-2009-2008, IN USD THOUSAND)

82. LIFE TECHNOLOGIES CORPORATION: BREAKDOWN OF NET REVENUES BY INDUSTRY SEGMENT - (2008-2009-2010, IN USD MILLION)

83. LIFE TECHNOLOGIES CORPORATION: BREAKDOWN OF NET REVENUES BY GEOGRAPHY - (2008-2009-2010, IN USD MILLION)

84. BD BIOSCIENCES: BREAKDOWN OF NET SALES BY INDUSTRY SEGMENTS - (2010-2009-2008, IN USD MILLION)

85. BD BIOSCIENCES: COMPANY REVENUES-GENERATING INTO THE FOLLOWING GEOGRAPHIC AREAS - (2010-2009-2008, IN USD MILLION)

86. BECKMAN COULTER: BREAKDOWN OF TOTAL REVENUE BY SEGMENT/CATEGORY (2009 AND 2008, IN USD MILLION)

87. BECKMAN COULTER: BREAKDOWN OF TOTAL REVENUE BY GEOGRAPHIC REGION - (2009 AND 2008, IN USD MILLION)

88. BECKMAN COULTER: INSTRUMENT SALES - (2009-2008-2007-2006-2005, IN USD MILLION)

89. BIO-RAD LABORATORIES, INC.: REVENUES GENERATING FOR THE INDUSTRY SEGMENTS - (2010-2009-2008, IN USD MILLION)

90. BIO-RAD LABORATORIES, INC.: NET SALES BY GEOGRAPHIC AREA - (2010-2009-2008 IN USD MILLION)

91. CALIPER LIFE SCIENCES, INC.: BREAKDOWN OF REVENUES BY SEGMENT - (2010 AND 2009, IN USD THOUSAND)

92. CALIPER LIFE SCIENCES, INC.: RESEARCH AND DEVELOPMENT EXPENSES - (2010-2009-2008, IN USD IN MILLION)

93. CALIPER LIFE SCIENCES, INC.: BREAKDOWN OF REVENUES BY GEOGRAPHY - (2010-2009-2008, IN USD THOUSAND)

94. CEPHEID: PRODUCT SALES IN THE CLINICAL, INDUSTRIAL, BIOTHREAT AND PARTNER MARKETS - (2010-2009-2008, IN USD THOUSAND)

95. CEPHEID: BREAKDOWN OF PRODUCT SALES BY GEOGRAPHIC REGIONS - (2010-2009-2008, IN USD THOUSAND)

96. COMPLETE GENOMICS, INC.: NET SALES AND RESEARCH AND DEVELOPMENT EXPENSES - (2009 AND 2010, IN USD THOUSAND)

97. ENZO BIOCHEM: BREAKDOWN OF SALES BY GEOGRAPHIC REGION - (2010-2009-2008, IN USD THOUSAND)

98. GE HEALTHCARE: CONSOLIDATED TOTAL NET REVENUES AND PROFITS BY INDUSTRY SEGMENT (2008-2009-2010, IN USD MILLION) & RESEARCH AND DEVELOPMENT EXPENSES (2008-2009-2010, IN USD BILLION)

99. GE HEALTHCARE: GEOGRAPHY BREAKDOWN OF NET REVENUES - (2010-2009-2008, IN USD BILLION)

100. ILLUMINA: NET REVENUES BY CATEGORY AND RESEARCH AND DEVELOPMENT EXPENSES - (2010-2009-2008, IN USD THOUSAND)

101. ILLUMINA: BREAKDOWN OF NET REVENUES BY GEOGRAPHY - (2010-2009-2008, IN USD THOUSAND)

102. QIAGEN, INC.: BREAKDOWN OF NET REVENUE BY GEOGRAPHY - (2010-2009-2008, IN USD THOUSAND)

103. QIAGEN, INC.: BREAKDOWN OF LEADING SEGMENTS AND TYPES - 2010 %AGE GROWTH RATES

104. ROCHE DIAGNOSTICS: PHARMACEUTICALS DIVISION MAJOR REGULATORY APPROVALS IN VARIOUS COUNTRIES FOR THE FIRST HALF OF 2011

105. ROCHE DIAGNOSTICS: PHARMACEUTICALS DIVISION MAJOR REGULATORY FILINGS IN VARIOUS COUNTRIES FOR THE FIRST HALF OF 2011

106. ROCHE DIAGNOSTICS: NET SALES BY INDUSTRY SEGMENTS AND RESEARCH AND DEVELOPMENT EXPENSES - (2010 AND 2011, IN MILLION CHF)

107. ROCHE DIAGNOSTICS: PHARMACEUTICALS DIVISION - NET SALES BY THERAPEUTIC AREA - (2011, IN MILLION CHF)

108. ROCHE DIAGNOSTICS: PHARMACEUTICALS DIVISION - NET SALES BY GEOGRAPHIC REGION - (2011, IN MILLION CHF)

109. ROCHE DIAGNOSTICS: DIAGNOSTICS DIVISION - NET SALES BY BUSINESS AREA - (2011, IN MILLION CHF)

110. ROCHE DIAGNOSTICS: DIAGNOSTICS DIVISION - NET SALES BY GEOGRAPHIC REGION - (2011, IN MILLION CHF)

111. THERMO FISHER SCIENTIFIC, INC.: BREAKDOWN OF TOTAL REVENUE BY SEGMENT & RESEARCH AND DEVELOPMENT EXPENSES - (2010-2009-2008, IN USD MILLION)

112. THERMO FISHER SCIENTIFIC, INC.: BREAKDOWN OF TOTAL REVENUE BY GEOGRAPHIC REGION - (2010-2009-2008, IN USD MILLION)

113. THERMO FISHER SCIENTIFIC, INC.: BREAKDOWN OF TOTAL REVENUE BY END-USE MARKET - (2010, IN USD MILLION)

114. THERMO FISHER SCIENTIFIC, INC.: BREAKDOWN OF TOTAL REVENUE BY PRODUCT CATEGORY - (2010, IN USD MILLION)

115. EPPENDORF AG: BREAKDOWN OF SALES BY GEOGRAPHIC REGION - (2010-2009-2008, IN GBP MILLION)

116. TAKARA BIO, INC.: BREAKDOWN OF NET SALES BY BUSINESS SEGMENT AND RESEARCH &DEVELOPMENT EXPENSES - (2008-2009-2010, IN MILLION OF YEN)

117. TAKARA BIO, INC.: BREAKDOWN OF NET SALES BY GEOGRAPHIC AREA - (2010, IN MILLION OF YEN)

Key Companies

NORTH AMERICA

ABBOTT LABORATORIES

AFFYMETRIX, INC.

AGILENT TECHNOLOGIES, INC.

LIFE TECHNOLOGIES CORPORATION

BD BIOSCIENCES

BECKMAN COULTER, INC.

BIONEER, INC.

BIO-RAD LABORATORIES, INC.

BIOTROVE

CALIPER LIFE SCIENCES, INC.

CEPHEID

COMBIMATRIX CORPORATION

COMMONWEALTH BIOTECHNOLOGIES, INC

COMPLETE GENOMICS, INC.

ENZO BIOCHEM

EPICENTRE® BIOTECHNOLOGIES

GE HEALTHCARE (LIFE SCIENCES)

GENISPHERE INC.

ILLUMINA

LI-COR BIOSCIENCES

LUCIGEN CORPORATION

MAXIM BIOTECH, INC

NANOGEN, INC.

PROMEGA CORPORATION

QIAGEN, INC.

SEQUETECH CORPORATION

VISIGEN BIOTECHNOLOGIES, INC.

DNA LANDMARKS, INC.

ROCHE DIAGNOSTICS (A DIVISION OF F.HOFFMANN-LA ROCHE LIMITED)

SPARTAN BIOSCIENCE INC

THERMO FISHER SCIENTIFIC, INC.

GENSCRIPT USA INC

EUROGENTEC

EUROPE

EPPENDORF AG

EUROFINS MEDIGENOMIX GMBH

FEBIT HOLDING GMBH

GENEART AG

CYTOCELL, LTD.

SHIMADZU BIOTECH

SACACE BIOTECHNOLOGIES S.R.L.

DNAVISION SA

EXIQON

BIOTAGE AB

LIGHTUP TECHNOLOGIES AB

MICROSYNTH AG

ASIA-PACIFIC

HOKKAIDO SYSTEM SCIENCE CO., LTD.

OCIMUM BIOSOLUTIONS LTD.

AGRIGEN BIOTECH PTY LTD

GENEWORKS PTY LTD

SATURN BIOTECH LIMITED

TAKARA BIO, INC.

REST OF WORLD

HY LABORATORIES LTD.

INQABA BIOTECHNICAL INDUSTRIES (PTY) LTD

Inquiry

Your Question:
Full Name:
Email:
Country:
Phone:

Request For Sample Pages of Report
Email:
*Note : Please use company email for better response